CAS: 38377-38-7; 4-Fluorophenyl Carbonochloridate

该化合物是一种反应性丙基氯仿酯酯,广泛用作有机合成的多用途中间体,特别是用于浸泡物联结和相互碰撞反应,其主要优势在于其高的电极性,能够在温和条件下有效地衍生胺,酒精和其他核素.电排氟替代氟化物与苯氯仿类相比,增强了其再活动性.该化合物因其在受控储存条件下的稳定性及其在引入四氟苯氧碳基保护组方面的效用而受到重视.它发现在药物和农用化学研究中的应用,在这些研究中,选择性的功能化至关重要.需要妥善处理,因为其湿度敏感度和含色性特性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4-Fluorophenol bis(trichloromethyl) carbonate trichloromethyl chloroformate 5-(Methoxyimino-methyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid 4-fluoro-phenyl ester 4-(tert-Butyl-dimethyl-silanyloxymethyl)-2-ethynyl-2H-quinoline-1-carboxylic acid 4-fluoro-phenyl ester bis(4-fluorophenyl) carbonate

合成工艺路线路线简述

    4-氟苯酚,三光气置于n,N-二乙基苯胺体系中,用 甲苯 用作溶剂,化学反应 2.0H,反应生成氯甲酸-4-氟苯酯
    参考文献:可见光诱导的分子内c(sp 2)-h胺化和叠氮基甲酰胺通过三重态硝基途径的叠氮化
    标题:可见光诱导的分子内c(sp 2)-h胺化和叠氮基甲酰胺通过三重态硝基途径的叠氮化
    摘要:邻烯丙基苯基叠氮基甲酸酯的催化分子内c-h氨基化和叠氮化反应已在可见光照射下完成,为合成有用的苯并恶唑酮和[5.1.0]双环氮丙啶提供了温和,清洁和有效的方法.机理研究表明,三重态氮烯起反应性中间体的作用.与烷基烯烃叠氮化≫缺电子烯烃叠氮化~c(sp 2)-h胺化≫ C(sp 3)-h胺化反应的化学选择性,在理解可见光方面可能具有指导意义诱导的三重态氮转化反应.
    Doi:10.1021/acs.Orglett.8B01980

    海关参考信息

    专利信息


    专利号:US-8377406-B1
    优先权日:2012-08-29
    标 题 :Synthesis of bis(fluorosulfonyl)imide
    发明人:SINGH RAJENDRA P; MARTIN JERRY LYNN; POSHUSTA JOSEPH CARL
    权利人:BOULDER IONICS CORP; SINGH RAJENDRA P; MARTIN JERRY LYNN; POSHUSTA JOSEPH CARL
    摘要:The present invention provides methods for producing bis(fluorosulfonyl) compounds of the formula:n nF—S(O) 2 —Z—S(O) 2 —F  In nby contacting a nonfluorohalide compound of the formula:n nX—S(O) 2 —Z—S(O) 2 —Xn nwith bismuth trifluoride under conditions sufficient to produce the bis(fluorosulfonyl) compound of Formula I, where Z and X are those defined herein.

    专利号:US-9453037-B2
    优先权日:2011-07-28
    标 题 :Methylphenidate-prodrugs, processes of making and using the same
    发明人:GUENTHER SVEN; CHI GUOCHEN; BERA BINDU; MICKLE TRAVIS; BERA SANJIB
    权利人:KEMPHARM INC; KEMPHARM INC
    摘要:The present technology is directed to prodrugs and compositions for the treatment of various diseases and/or disorders comprising methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof. In some embodiments, the conjugates further include at least one linker. The present technology also relates to the synthesis of methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof or combinations thereof.

    专利号:US-5132468-A
    优先权日:1990-01-19
    标题 :C-alkylation of hydroquinone or monoethers thereof
    发明人:DOUSSAIN CLAUDE; GUBELMANN MICHEL; TIREL PHILIPPE-JEAN
    权利人:RHONE POULENC CHIMIE
    摘要:The alkyl hydroquinones, e.g., methyl hydroquinone (a useful intermediate in the preparation of the monomer methyl hydroquinone diacetate, itself used for the synthesis of thermotropic polymers), are prepared by reacting (C-alkylating) hydroquinone or a monoether thereof with a lower alkanal, in the vapor phase, with a catalytically effective amount of at least one solid metal oxide.

    专利号:US-9895454-B2
    优先权日:2014-07-03
    标题:Metal oxide catalyzed radiofluorination
    发明人:SERGEEV MAXIM; MORGIA FEDERICA; VAN DAM ROBERT MICHAEL; LAZARI MARK
    权利人:UNIV CALIFORNIA
    摘要:Inter alia, the first titania-catalyzed [ 18 F]-radiofluorination in highly aqueous medium is provided. In embodiments, the method utilizes titanium dioxide, 1:1 acetonitrile-thexyl alcohol solvent mixture and tetrabutylammonium bicarbonate as a base. Radiolabeling may be directly performed with aqueous [ 18 F]fluoride without the need for drying/azeotroping step, which reduces radiosynthesis time while keeping high fluoride conversion. The general applicability of the synthetic strategy to the synthesis of the wide range of PET probes from tosylated precursors is demonstrated.

    专利号:US-5521179-A
    优先权日:1991-04-18
    标题 :Heterocyclic amides
    发明人:BERNSTEIN PETER R; SHAW ANDREW; THOMAS ROYSTON M; WARNER PETER; WOLANIN DONALD J
    权利人:ZENECA LTD
    摘要:The present invention relates to certain novel heterocyclic amides which are 1-pyridylacetamide compounds of formula I, set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic amides, processes for preparing the heterocyclic amides, pharmaceutical compositions containing such heterocyclic amides and methods for their use.

    专利号:AU-2013309495-A1
    优先权日:2012-08-29
    标题 :Synthesis of bis(fluorosulfonyl)imide
    友顺精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.usunfc.com
    企业联系电话:025-84574075;84574691👤
    📞友顺精细化工有限公司 ⚠️参考联系方式
    联系人:销售部
    电话:025-84574075;84574691

    传真:025-84574930
    邮箱:sales@usunfc.com
    通信地址: 南京市建邺区云龙山路89号龙湖时代上城1栋1005室
    邮编: 210019
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:南京市建邺区云龙山路89号龙湖时代上城1栋1005室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    南京友顺精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.usunfc.com
    电话: 025-84574075👤
    📞南京友顺精细化工有限公司 ⚠️参考联系方式

    销售电话:025-84574075
    邮箱:sales@usunfc.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:洪武路359号福鑫国际大厦
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1002/chem.201303241
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知